Physician profile
Anna Alexander
NPI 1770207714
$2,246.03
in general payments reported to CMS, 2019-2025
30 companies · $1,193 in 2025
The $1,193 reported for 2025 was more than what 86% of Physician Assistant providers received nationally (typical 2025 total: $183).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2022: $17.77 · 2023: $505 · 2024: $531 · 2025: $1,193.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $2,133 · Education: $94.99.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $2,133.27 |
| Education | $94.99 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Aop Health US, LLC | $372.11 | 2025 | Rapiblyk |
| Novo Nordisk INC | $195.85 | 2023-2025 | Ozempic, Rybelsus, Wegovy |
| Abbvie INC. | $168.05 | 2023-2025 | |
| Salix Pharmaceuticals, A Division of Bausch Health US, LLC | $156.24 | 2023-2025 | Xifaxan, Trulance |
| Lilly USA, LLC | $140.36 | 2023-2025 | Zepbound, Mounjaro, Jardiance |
| Pfizer INC. | $121.29 | 2025 | |
| Astellas Pharma US INC | $120.48 | 2023 | Myrbetriq |
| Astrazeneca Pharmaceuticals Lp | $114.53 | 2023-2025 | Airsupra, Breztri, Farxiga |
| Glaxosmithkline, LLC. | $111.27 | 2023-2025 | Trelegy Ellipta, Shingrix, Arexvy |
| Amgen INC. | $95.10 | 2023-2025 | Repatha, Otezla, Repatha |
| Exact Sciences Corporation | $84.31 | 2023-2025 | Cologuard Collection Kit |
| Dexcom, INC. | $73.53 | 2023-2024 | Dexcom G6 Transmitter |
| Sumitomo Pharma America, INC. | $63.52 | 2025 | Gemtesa |
| Phathom Pharmaceuticals, INC. | $50.83 | 2024 | Voquezna |
| Organon LLC | $42.79 | 2023 | Nexplanon |
Show all 30 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Sanofi-Aventis U.S. LLC | $42.39 | 2025 | |
| Boehringer Ingelheim Pharmaceuticals, INC. | $31.60 | 2024 | Jardiance |
| Kowa Pharmaceuticals America, INC. | $30.70 | 2025 | Zoryve |
| Hologic Sales and Service, LLC | $29.23 | 2024 | Thinprep 2000 Processor |
| Octapharma USA, INC. | $25.02 | 2025 | Balfaxar |
| Renalytix Ai, INC. | $23.88 | 2024 | Kidneyintelx Blood Collection Convenience Kit |
| Takeda Pharmaceuticals U.S.A., INC. | $22.47 | 2025 | Trintellix |
| Azurity Pharmaceuticals, INC. | $22.29 | 2023 | Edarbi |
| Inogen, INC. | $20.64 | 2025 | |
| Gilead Sciences, INC. | $18.05 | 2025 | |
| Aspira Women'S Health INC | $17.77 | 2022 | |
| Alk-Abello, INC | $17.64 | 2024 | Grastek, Ragwitek, Odactra |
| Esperion Therapeutics, INC. | $13.60 | 2025 | Nexletol |
| Idorsia Pharmaceuticals US INC | $12.99 | 2023 | Quviviq |
| Mayne Pharma Commercial LLC | $7.50 | 2023 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Anna Alexander listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.